You are here

  • Home
  • Archive
  • Volume 15, Issue 4
  • Treatment of a ruptured fetal-type posterior communicating aneurysm with a combined approach using the new contour neurovascular system

Article Text

Article menu
Download PDFPDF
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Treatment of a ruptured fetal-type posterior communicating aneurysm with a combined approach using the new contour neurovascular system
  1. Nicola Cavasin1,
  2. Umberto Amedeo Gava1,
  3. Salima Magrini2 and
  4. Enrico Cagliari1
  1. 1Neuroradiology, Ospedale dell'Angelo, Mestre, Italy
  2. 2Neurosurgery, Ospedale dell'Angelo, Mestre, Italy
  1. Correspondence to Dr Nicola Cavasin; nicola.cavasin{at}aulss3.veneto.it

Abstract

Fetal-type posterior communicating artery (FPCom) aneurysms are associated with higher rates of recurrence after endovascular treatment than aneurysms at other locations. We report the case of a patient with a subarachnoid haemorrhage and ruptured right-sided FPCom aneurysm. The patient underwent acute endovascular treatment with application of a novel combined approach—partial coiling to protect the dome and occlusion of the neck with a new flow-disrupter, endosaccular device, Contour (Cerus Endovascular)—as a stable, single-step treatment to prevent rebleeding in the acute stage and long-term potential recurrences.

  • Neurology
  • Headache (including migraines)

https://doi.org/10.1136/bcr-2021-248065

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors Conceptualisation, writing—original draft preparation, NC; writing—review and editing, UAG and SM; supervision, EC. All authors have read and agreed to the published version of the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.